ANNX: Annexon, Inc.
Performance
ANNX +46.87%
Watchlist
Select an item
Summary
ANNX at a glance
ANNX returned +46.88% over the past year and -22.83% a year over five years. Its worst drop in that year was -51.01%, smaller than 22% of stocks on Redstone, and its Sharpe ratio of 0.83 beats 68% of stocks on Redstone. It pays no dividends.
Current Drawdown
-39.22%
Rolling Volatility
84.44%
Actions
Metrics
Risk Indicators
Alpha47.41%
Beta1.49x
Sharpe0.83
Sortino1.45
Omega1.16
Calmar0.92
Martin2.47
Profile
About ANNX
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $802M
- Listed
- Jul 2020
- Employees
- 92
- Headquarters
- Brisbane, CA
- Website
- annexonbio.com
Comparisons